Target intelligence / Profile preview

Transmembrane protein 233 (TMEM233)

Target
TMEM233
Molecular classification
Transmembrane protein, Accessory protein of voltage-gated sodium channels, Dispanin family (subfamily B), Other
01

Overview

Transmembrane protein 233 (TMEM233) is an accessory transmembrane protein primarily expressed in sensory neurons, classified within the dispanin subfamily B family. TMEM233 is required for the pharmacological and toxicological effects of certain plant-derived peptide toxins, notably ExTxA, on the voltage-gated sodium channel NaV1.7, a critical component in nociceptive (pain-sensing) neurons. TMEM233 binds these toxins and, in conjunction with NaV1.7, alters the channel’s inactivation properties, promoting persistent sodium currents and increased cellular excitability. Its structure includes at least one membrane-spanning domain with extracellular C-terminus and intracellular N-terminus. Genetic association studies list TMEM233 in the context of osteogenesis imperfecta type V, but its primary characterized physiological and pathological function relates to pain modulation and sodium channel accessory protein function[1][2][4][5].

Other names
IFITMD2DSPB2Dispanin subfamily B member 2Interferon-induced transmembrane domain-containing protein D2Interferon induced transmembrane protein domain containing 2
02

Mechanism of action

Modulation of sodium channel (NaV1.7) gating through physical interaction enabling toxin (ExTxA) action

03

Biological functions

Modulation of voltage-gated sodium channel (NaV) gatingRegulatory role in sensory neuron excitabilityAccessory protein for channel toxin sensitivity
04

Disease associations

Pain (nociceptive signaling, toxin-induced pain)Osteogenesis imperfecta (type V, genetic association)
05

Safety considerations

Potential for modulating pain and neuronal excitability; specific therapeutic safety concerns not established in literature
06

Interacting drugs

ExTxA (plant-derived peptide toxin, modulates sodium channel function via TMEM233)

Beyond the preview

Go deeper on Transmembrane protein 233 (TMEM233).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Transmembrane protein 233 (TMEM233).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call